Alireza Radmanesh

Alireza Radmanesh

Auto-generated profile, based on publicly available information

Alireza Radmanesh

From the Department of Radiology, New York University Grossman School of Medicine, 660 First Ave, 2nd Floor, New York, NY 10016

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Open access
MMMatthew J. Muckley
Matthew J. Muckley
BRBruno Riemenschneider
Bruno Riemenschneider
ARAlireza Radmanesh
Alireza Radmanesh
SKSunwoo Kim
Sunwoo Kim
GJGeunu Jeong
Geunu Jeong
FKFlorian Knoll
Florian Knoll
Accelerating MRI scans is one of the principal outstanding problems in the MRI research community. Towards this goal, we hosted the second fastMRI competition targeted towards reconstructing MR images with subsampled k-space data. We provided participants with data from 7,299 clinical brain scans (de-identified via a HIPAA-compliant procedure by NYU Langone Health), holding back the fully-sampled data from 894 of these scans for challenge evaluation purposes. In contrast to the 2019 challenge, we focused our radiologist evaluations on pathological assessment in brain images. We also debuted a new Transfer track that required participants to submit models evaluated on MRI scanners from outside the training set. We received 19 submissions from eight different groups. Results showed one team scoring best in both SSIM scores and qualitative radiologist evaluations. We also performed analysis on alternative metrics to mitigate the effects of background noise and collected feedback from the participants to inform future challenges. Lastly, we identify common failure modes across the submissions, highlighting areas of need for future research in the MRI reconstruction community.

1 October 2020 in Radiology
Verified
Journal Article
Closed access
ARAlireza Radmanesh
Alireza Radmanesh
ADAnna Derman
Anna Derman
YLYvonne W. Lui
Yvonne W. Lui
EREytan Raz
Eytan Raz
JLJohn P. Loh
John P. Loh
GFGirish M. Fatterpekar
Girish M. Fatterpekar
Coronavirus disease 2019 (COVID-19) has been reported in association with a variety of brain imaging findings such as ischemic infarct, hemorrhage, and acute hemorrhagic necrotizing encephalopathy....

18 June 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
DCD.D. Cavalcanti
D.D. Cavalcanti
EREytan Raz
Eytan Raz
MSM. Shapiro
M. Shapiro
SDS. Dehkharghani
S. Dehkharghani
SYS. Yaghi
S. Yaghi
PNP.K. Nelson
P.K. Nelson
Despite the severity of coronavirus disease 2019 (COVID-19) being more frequently related to acute respiratory distress syndrome and acute cardiac and renal injuries, thromboembolic events have been increasingly reported. We report a unique series of young patients with COVID-19 presenting with cerebral venous system thrombosis. Three patients younger than 41 years of age with confirmed Severe Acute Respiratory Syndrome coronavirus 2 (SARS-Cov-2) infection had neurologic findings related to cerebral venous thrombosis. They were admitted during the short period of 10 days between March and April 2020 and were managed in an academic institution in a large city. One patient had thrombosis in both the superficial and deep systems; another had involvement of the straight sinus, vein of Galen, and internal cerebral veins; and a third patient had thrombosis of the deep medullary veins. Two patients presented with hemorrhagic venous infarcts. The median time from COVID-19 symptoms to a thrombotic event was 7 days (range, 2-7 days). One patient was diagnosed with new-onset diabetic ketoacidosis, and another one used oral contraceptive pills. Two patients were managed with both hydroxychloroquine and azithromycin; one was treated with lopinavir-ritonavir. All patients had a fatal outcome. Severe and potentially fatal deep cerebral thrombosis may complicate the initial clinical presentation of COVID-19. We urge awareness of this atypical manifestation.

1 July 2010 in Brain and Cognition
Verified
Journal Article
Closed access
RPRuth Propper
Ruth Propper
LOLauren J. O’dOnnell
Lauren J. O’dOnnell
SWStephen Whalen
Stephen Whalen
YTYanmei Tie
Yanmei Tie
INIsaiah H. Norton
Isaiah H. Norton
AGAlexandra J. Golby
Alexandra J. Golby

28 May 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
ARA. Radmanesh
A. Radmanesh
EREytan Raz
Eytan Raz
EZE. Zan
E. Zan
ADA. Derman
A. Derman
MKM. Kaminetzky
M. Kaminetzky
Coronavirus disease 2019 (COVID-19) is a serious public health crisis and can have neurologic manifestations. This is a retrospective observational case series performed March 1-31, 2020, at New York University Langone Medical Center campuses. Clinical and imaging data were extracted, reviewed, and analyzed. Two hundred forty-two patients with COVID-19 underwent CT or MRI of the brain within 2 weeks after the positive result of viral testing (mean age, 68.7 ± 16.5 years; 150 men/92 women [62.0%/38.0%]). The 3 most common indications for imaging were altered mental status (42.1%), syncope/fall (32.6%), and focal neurologic deficit (12.4%). The most common imaging findings were nonspecific white matter microangiopathy (134/55.4%), chronic infarct (47/19.4%), acute or subacute ischemic infarct (13/5.4%), and acute hemorrhage (11/4.5%). No patients imaged for altered mental status demonstrated acute ischemic infarct or acute hemorrhage. White matter microangiopathy was associated with higher 2-week mortality (P < .001). Our data suggest that in the absence of a focal neurologic deficit, brain imaging in patients with early COVID-19 with altered mental status may not be revealing.

1 March 2015 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
JGJacob K. Greenberg
Jacob K. Greenberg
CYChester K. Yarbrough
Chester K. Yarbrough
ARAlireza Radmanesh
Alireza Radmanesh
JGJakub Godzik
Jakub Godzik
MYMegan Yu
Megan Yu
DLDavid D. Limbrick
David D. Limbrick
BACKGROUND:. To develop evidence-based treatment guidelines for Chiari malformation type 1 (CM-1), preoperative prognostic indices capable of stratifyin